Patent for BioProspect

By Staff Writers
Monday, 20 October, 2008

Brisbane company BioProspect (ASX: BPO) has been granted a patent on its Termilone product for termite control.

Termoline is based on ermophilone oil, extracted from the native Australian tree False Sandalwood.

The oil acts as both a toxic agent on termites and a repellant, but has shown low toxicity in mammalian species.

The company is also developing a range of Bioeffectives for the animal health and nutrition markets.

Designed to support Australia's homegrown life sciences innovation, AusBiotech has announced...

After the WHO determined the outbreak of Ebola in the DRC and Uganda to be a public health...

To respond to the biggest diphtheria outbreak on record, support has been announced for the NT...

Content from other channels on our network

Six key pillars of frailty prevention and management

Protecting the people who protect us: PPE continuity during demand surge

WA steps in to ensure 'continuity' of operations at Mount Private Hospital

What healthcare boards need from risk leaders

Additional $22.9m in research grants for nation's biggest killer

SA retirement village reduces energy costs using solar system

How do we prepare for a hotter, more populated, Sydney?

Battery-free sensors close to reality

Flux Marine Redefines Marine Propulsion Through Electrification

Australian industry won't hit net zero if organisations hoard their data

Redesigning for decarbonisation: the shift towards electrified hydraulic power

Chinese humanoid robot manufacturer opens mass production plant

A guide to a cost-effective SIS

NSW launches Local Jobs First Commission legislation

What if your machines could talk? Now they can: meet MYZEL by Pilz